CTOs on the Move

Cenegenics

www.cenegenics.com

 
Get a personalized medical team of experts that tests for and treats the earliest signs and avoidable symptoms associated with chronic disease and aging.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.cenegenics.com
  • 851, South Rampart Boulevard
    Las Vegas, NV USA 89145
  • Phone: 702.953.1583

Executives

Name Title Contact Details

Similar Companies

Activecare Network

Activecare Network is a Bannockburn, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Centerlight Health System

CenterLight Health System ranks among the nation`s leading resources for long-term residential and community-based health care. A voluntary, nonprofit organization, CenterLIght has made life better for tens of thousands of New Yorkers from all backgrounds and walks of life. It first opened its doors to the poor, chronically ill and disabled just after the First World War.

Calhoun Senior Living

Calhoun Senior Living is a Anderson, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aver Informatics

Aver Informatics` patented data analytics platform radically simplifies the healthcare reimbursement process. Through analyzing the vast amounts of "fee for service" data already available in current healthcare claims systems, Aver automatically packages patient care services into episodic bundles, making the payment process simple for each the payer, provider and patient.

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.